Due to their significant role in numerous cellular mechanisms closely associated with cancers, HSPGs, such as SDC4, and HSPG-related genes such as AKT1 and ATM present an exciting target for BC diagnostics and macromolecular drug therapies. This evidence concerns the gene SDC4 and breast cancer.